Mode
Text Size
Log in / Sign up

Pancreaticoduodenectomy for unclassified duodenal spindle cell tumor shows no recurrence by May 2025A rare abdominal tumor shows no signs of returning

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider pancreaticoduodenectomy for unclassified duodenal spindle cell tumors, but note diagnostic limitations and need for long-term surveillance.

This case report details the management of a 55-year-old woman presenting with abdominal discomfort, nausea, and vomiting, who was found to have a duodenal mesenchymal spindle cell tumor. The tumor was surgically resected via pancreaticoduodenectomy. Pathological examination revealed a submucosal spindle cell tumor with 2 mitoses per 50 high-power fields, hemorrhage, inflammatory exudates, focal infiltrative growth, and limited invasion of adjacent pancreatic tissue. Immunohistochemistry showed negativity for DOG-1, CD117, desmin, and CD34, but positivity for SMA, with weak cytoplasmic β-catenin staining and no nuclear accumulation. The tumor was ultimately designated as 'unclassified duodenal mesenchymal spindle cell tumor with SMA expression' due to insufficient markers for definitive lineage assignment.

Follow-up included four abdominal CTs and one MRI through May 28, 2025, with no definite recurrence or metastasis detected. The authors highlight the limitations of superficial biopsy, which was non-representative, and note that the expanded IHC panel was insufficient for definitive lineage assignment. They emphasize the need to integrate diagnostic uncertainty, resectability, vascular proximity, and operative safety when managing complex periduodenal tumors.

As a single case report, these findings are not generalizable, and the lack of a comparator and long-term follow-up limits conclusions about the effectiveness of pancreaticoduodenectomy in this setting. The favorable short-term outcome is encouraging but should be interpreted cautiously.

Imagine feeling constant stomach discomfort and nausea, only to find out it is caused by a rare type of growth in the small intestine. This was the reality for a 55-year-old woman who underwent surgery to remove a tumor near her duodenum. Because the tumor was located near vital organs, doctors had to navigate a complex surgical path to ensure her safety.

The tumor was identified as a mesenchymal spindle cell tumor. These are rare growths that can be difficult to categorize exactly because they don't always react predictably to standard tests. In this case, initial tests were not enough to give a perfect diagnosis of the tumor's exact lineage. However, the surgical team successfully removed the growth and monitored her closely.

Since the surgery, follow-up scans including CT scans and an MRI have shown no signs of the cancer coming back or spreading as of May 2025. This case serves as a reminder that while some tumors are hard to identify perfectly at first, surgical removal can be effective. It also highlights why doctors must carefully weigh the risks of surgery against the uncertainty of a diagnosis.

What this means for you:
A patient with a rare intestinal tumor showed no signs of recurrence following successful surgical removal.

Common questions

What kind of tumor was found?

The patient had a duodenal mesenchymal spindle cell tumor. This is a rare type of growth in the tissue near the small intestine. Because certain markers were missing during testing, doctors could not give it a specific lineage name, but they identified its primary characteristics through surgery and imaging.

Did the cancer spread after surgery?

No. Follow-up scans including four abdominal CTs and one MRI showed no definite recurrence or metastasis as of May 28, 2025. This means the tumor did not appear to come back or spread to other parts of the body during the monitoring period.

Why was the initial diagnosis difficult?

The initial biopsy was superficial, meaning it only took a small sample from the surface. This can sometimes lead to an incomplete picture of the tumor's full nature. Because of this, doctors had to use additional tests that still could not provide a definitive lineage assignment for the growth.

Study Details

Study typeSystematic review
EvidenceLevel 1
PublishedAug 2026
View Original Abstract ↓
Duodenal mesenchymal spindle cell tumors are uncommon and may overlap radiologically with gastrointestinal stromal tumors (GISTs) and retroperitoneal lesions. We report a 55-year-old woman with abdominal discomfort, nausea, and vomiting. Contrast-enhanced computed tomography demonstrated an approximately 6.0 × 3.8 cm mass posterior to the pancreatic head that was interpreted as a probable duodenal stromal tumor. Gastroscopic biopsy was non-representative. Given the symptoms, tumor size, uncertain origin, and vascular proximity, surgical exploration was undertaken. The tumor was firm and densely adherent to the inferior vena cava, and pancreaticoduodenectomy was performed. Supplementary pathological review showed a submucosal spindle cell tumor with 2 mitoses per 50 high-power fields, hemorrhage and inflammatory exudates, focal infiltrative growth, and limited invasion of adjacent pancreatic tissue. DOG-1, CD117, desmin, and CD34 were negative; SMA was positive, and β-catenin showed only weak cytoplasmic staining without nuclear accumulation. The expanded panel remained insufficient for definitive lineage assignment, and the lesion was designated an unclassified duodenal mesenchymal spindle cell tumor with SMA expression. Four abdominal computed tomography examinations and one magnetic resonance imaging examination showed no definite recurrence or metastasis through May 28, 2025. This case illustrates the limitations of superficial biopsy and shows that management of an anatomically complex periduodenal tumor may need to integrate diagnostic uncertainty, resectability, vascular proximity, and operative safety.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.